Zynerba Pharmaceuticals Inc. (ZYNE) Fundamentals

Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system.
SHARE INFORMATION
Market Cap$ 52,939,301
Shares Outstanding44,863,814
Float42,950,724
Percent Float95.74%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.93
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions116
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months649,389
Institutional Holdings Percent55.5%
Institutional Sold Previous 3 Months2,204,237
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months455,396
Insider Holdings Percent6.9
Insider Sold Previous 3 Months30,735
Insider Shares Owned3,077,120
TRADING INFO
52 Week High$ 4.67
52 Week Low$ 0.84
52 Week High Change$ -72.75
21 Day Moving Average$ 1.1543
21 Day Extended Moving Average$ 1.156
50 Day Moving Average$ 1.1069
50 Day Extended Moving Average$ 1.1912
200 Day Moving Average$ 2.209
200 Day Extended Moving Average$ 2.0899
10 Day Average Volume368,763
20 Day Average Volume404,562
30 Day Average Volume406,757
50 Day Average Volume590,963
Alpha-0.026244
Beta1.8630
Standard Deviation0.281741
R20.109386
7 Day Price Change$ 0.03
7 Day Percent Change2.61%
21 Day Price Change$ 0.06
21 Day Percent Change5.36%
30 Day Price Change$ 0.01
30 Day Percent Change0.85%
Month to Date Price Change$ 0.04
Month to Date Percent Change3.51%
Quarter to Date Price Change$ 0.04
Quarter to Date Percent Change3.51%
180 Day Price Change$ -1.49
180 Day Percent Change-55.81%
200 Day Price Change$ -1.45
200 Day Percent Change-55.13%
Year to Date Price Change$ -1.70
Year to Date Percent Change-59.03%

Zynerba Pharmaceuticals Inc. (ZYNE) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.80
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio8.20
Leverage Ratio1.10
Quick Ratio8.00
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.20
Enterprise Value$ -16,700,937
Price to Sales0.00
Price to Free Cash-3.00
PE High Last 5 Years-4.70
Price To Book0.80
Price To Cash Flow0.00
PE Low Last 5 Years-2.10
Price to Tangible Book0.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-41.31
Return on Equity-47.04
Return on Capital-46.82

Zynerba Pharmaceuticals Inc. (ZYNE) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOArmando Anido
Emplyoees28
Last AuditUQ
CIK0001621443
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address80 West Lancaster Avenue
Suite 300
Devon, PA 19333
Websitehttp://www.zynerba.com
Facsimile-
Telephone+1 484 581-7505
Emailrobertsw@zynerba.com


Your Recent History
NASDAQ
ZYNE
Zynerba Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.